By Marcus A. Banks
AMCP is spearheading an effort to encourage payors to utilize real-world evidence (RWE) in their decisions, and manufacturers to collect real-world data from sources like electronic health records as well as traditional clinical trial metrics.
“RWE often captures different information and different variables that are not part of clinical trials,” said Cate Lockhart, PharmD, PhD, the chief science officer for AMCP, who leads the organization’s Real-World